Fibronectin fragments active in chondrocytic chondrolysis can be chemically cross-linked to the alpha5 integrin receptor subunit  by Homandberg, G.A. et al.
Osteoarthritis and Cartilage (2002) 10, 938–949
© 2002 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved. 1063–4584/02/$35.00/0
doi:10.1053/joca.2002.0854, available online at http://www.idealibrary.com on
International
Cartilage
Repair
SocietyFibronectin fragments active in chondrocytic chondrolysis can be
chemically cross-linked to the alpha5 integrin receptor subunit
G. A. Homandberg*, V. Costa and C. Wen
Department of Biochemistry, Rush Medical College at Rush-Presbyterian-St Luke’s Medical Center,
1653 West Congress Parkway, Chicago, IL 60612-3864, U.S.A.
Summary
Objective: To determine whether fibronectin fragments (Fn-f) known to enhance cartilage matrix degradation and to alter chondrocyte
metabolism, bind on the chondrocyte cell surface close enough to the alpha5beta1 fibronectin (Fn) receptor to be chemically cross-linked
to it.
Design: Biotinylated Fn-fs were added to chondrocytes, followed by cross-linking with dithiobissulfosuccinimidyl propionate, and the
resultant alpha5 complexes trapped on to antialpha5-agarose. Adherent material was analysed by probing with avidin-HRP. In a more specific
approach in which only proximal targets could be cross-linked, photoaffinity labeled Fn-fs or Fn were added to cells, the derivatives activated
and the cross-linked material analysed. Interaction of biotinylated Fn-fs and Fn with insolubilized alpha5beta1 receptor was also visualized
and quantified.
Results: Biotinylated Fn-fs and Fn, but not a control of BSA, were cross-linked to alpha5 protein in the presence of the propionate.
Photoaffinity label Fn-f and Fn, but not BSA, were cross-linked to alpha5 protein as well. Interaction was decreased by addition of an excess
of unlabeled Fn-f or Fn. Fn-fs bound to alpha5beta1-agarose, although the affinity was 30-fold weaker and the stoichiometry 20-fold greater
when the smallest Fn-f was compared to native Fn.
Conclusions: These data are consistent with a role for the alpha5 subunit in Fn-f activities and suggest that the Fn-fs bind proximal or directly
to alpha5 receptors. The weaker, higher stoichiometry interaction of Fn-fs with receptor suggests that fragmentation has allowed de novo
interactions not possible in native Fn.
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Fibronectin (Fn) is a cell matrix and circulating protein that
is degraded readily into fragments (Fn-fs) by many different
types of proteinases. For example, the levels of Fn-fs are
greatly elevated in synovial fluids of patients with osteo-
arthritis (OA) and rheumatoid arthritis (RA)1–5. This might
contribute greatly to the pathologic state of OA since these
Fn-fs can penetrate cartilage tissue to surround chondro-
cytes6, to up-regulate matrix metalloproteinase (MMP)
expression6–10 and to suppress synthesis of proteoglycan
(PG)11–13. These activities occur at least partly through Fn-f
mediated release of the catabolic cytokines, TNF-, IL-1,
IL-1 and IL-610,14. These accumulative catabolic activities
result in severe cartilage damage in vitro7,11, as well as in
an in vivo model of cartilage damage15,16. The major
characteristics of this cartilage damage model have been
reviewed17.938Little is known of how the Fn-fs exert their activities. We
have recently implicated the classical alpha5beta1 integrin
by demonstrating that antisense oligonucleotides to the
alpha5 subunit partially reversed the catabolic activities of
three different cartilage chondrolytic Fn-fs, whether tested
in cartilage explant or in chondrocyte cultures18. This
receptor is the major Fn receptor found in chondrocytes19
and has been shown to be involved in matrix interactions
of chondrocytes and regulation of proliferation20 and to
mediate adhesion of chondrocytes to Fn21. This integrin
has also been shown to be involved in Fn-f mediated
signaling in rabbit synovial cells22. Our own data also show
that antibodies to the receptor suppress PG synthesis as
do Fn-fs (unpublished). Interestingly, we have shown that
the Arg-Gly-Asp-Ser sequence which is found in Fn and
which is responsible for binding this receptor can be
mutated to analog peptides that block activities of the
Fn-fs23. These data support the notion that the Fn-fs
mediate their activities through this receptor.
Although our work with antisense oligonucleotides to the
alpha5 subunit demonstrated a role of this subunit in Fn-f
activities, the involvement of this subunit could have been
indirect. For example, a co-operative interaction of different
integrins or other receptors might exist in which the alpha5
containing receptor is a downstream mediator of Fn-f
activities and does not physically interact with the Fn-f or
interact at sites physically near binding sites for Fn-f. Thus,
our objective was to determine, by use of cross-linking
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Except where noted, all common chemical reagents
and chromatography resins were from Sigma Chemical Co.
(St. Louis, MO). N-hydroxysuccinimidyl-biotin (NHS-biotin),
sulfosuccinimidyl-6-(biotinamido)hexanoate-NHS-biotin
(sulfo-NHS-LC-biotin), NHS-rhodamine [5-(and 6)-car-
boxylfluorescein, succinimidyl ester], avidin-horse radish
peroxidase (avidin-HRP) (161 Units peroxidase activity/mg
protein; 7 units avidin/mg protein), (dithiobis)sulfosuccini-
midyl propionate (DTSSP), sulfosuccinimidyl 2-(7-azido-4-
methylcoumarin-3-acetamide) ethyl-1,3′-dithiopropionate
(SAED), Reacti-Gel (6×) (1,1′ carbonyldiimidazole acti-
vated 6% cross-linked beaded agarose), and supplies for
chemiluminescent detection were from Pierce Chemical
Co. (Rockford, IL). The Enhanced Chemiluminescent
(ECL) kit used for Western blot detection was the Super
Signal Chemiluminescent Substrate kit for HRP from Pierce
Chemical Co. (Rockford, IL). Dulbecco’s modified Eagle’s
medium (DMEM), penicillin-streptomycin and avidin-
agarose (epichlorohydrin-activated) were from Sigma
Chemical Co. (St. Louis, MO) Polyclonal affinity purified
rabbit antibody to integrin alpha5 (CDw49e) (with cross-
reactivity to human, bovine, chicken, rat and mouse) was
from Chemicon International Inc. (Temecula, CA). Integrin
alpha5beta1 (VLA-5) purified from smooth muscle and
placental tissue under nondenaturing conditions by
affinity chromatography on Fn-Sepharose was purchased
from Chemicon International Inc. (catalogue no. CC1052).
125I-Bolton-Hunter reagent (2000 Ci/mmol) was from
Amersham Pharmacia Biotech Amersham Life Sciences
(Arlington Heights, IL).Methods
ISOLATION OF FN-FS AND FN
Fn was isolated from human plasma by adsorption to
gelatin-Sepharose and elution with 3 M urea. A well-
characterized amino-terminal heparin-binding 29-kDa
Fn-f and a gelatin-binding 50-kDa Fn-f were isolated by
sequential cathepsin D and thrombin digests of human
plasma Fn as described7. A mixture of non-gelatin binding
C-terminal Fn-containing the cell-binding 70–140-kDa Fn-fs
as well as smaller C-terminal Fn-fs was also studied and is
referred to as the 140-kDa Fn-f. Quantitation of Fn-f was
performed by use of the extinctions coefficients24.PREPARATION AND CHARACTERIZATION OF BIOTINYLATED FN-FS
AND PHOTOAFFINITY LABELED BIOTINYLATED FN-FS
Protein was biotinylated by reaction of 0.5 mg/ml protein
in 50 mM sodium bicarbonate buffer, pH 8.2, with 0.1 mg/
ml NHS-LC-biotin for 2 h on ice as directed by the manu-
facturer. The solution was subsequently dialysed against
50 mM phosphate buffer, pH 7.4, containing 150 mM NaCl.
To confirm that biotinylation had not altered Fn-f activity, the
effects of the rate of degradation of cartilage PG were
determined by measuring the kinetics of PG release into
the culture media as described5,6. At 1 M concentrations,
the labeled 29-kDa, 50-kDa and 140-kDa Fn-fs, retained,
respectively, 87 (±) 13 (n=3 separate culture wells), 95 (±)18 (n=3) and 105 (±) 8 (n=3) % of the activities of the
native, non-biotinylated Fn-fs. Native Fn has very low
activity in this assay and so similar comparisons were not
made.
To prepare photoaffinity labeled proteins, 0.5 mg/ml bio-
tinylated BSA, Fn-fs and Fn solutions were dialysed against
0.1 M phosphate, pH 8. To 0.5 ml volumes were added
0.2 ml of 2 mg/ml SAED in water with only a dark room red
safety lamp for illumination. After 2 h, 100 l of 0.1 M Gly,
pH 8, were added to quench unreacted groups. The solu-
tion was dialysed subsequently in the dark against 50 mM
phosphate buffer, pH 7.4, containing 150 mM NaCl, fol-
lowed by sterile filtration. To test activities of the derivatives,
aliquots were activated with UV light and then assayed for
PG degradation activity as described5,6. The resultant
activities for the 29-kDa, 50-kDa and 140-kDa activities
were 79 (±) 15% (n=3 separate culture wells), 87 (±) 14%
(n=3) and 92 (±) 4% (n=3) of the respective native,
non-biotinylated Fn-fs.ISOLATION OF CHONDROCYTES FOR MONOLAYER CULTURES
Articular cartilage was removed aseptically from the
metacarpophalangeal joints of 18–20-month-old bovines
and chondrocytes isolated as described9. The resulting cell
suspension was washed repeatedly, cells counted and the
cells plated in DMEM/10% FBS by addition of nine million
cells in 5 ml to a 6 cm dish. The media were changed every
other day and typically 3 or 4 days after plating, the media
were changed to DMEM and the experiments begun.VISUALIZATION OF INTERACTION OF BIOTINYLATED FN-F WITH
CARTILAGE AND OF RHODAMINE LABELED-FN-F INTERACTION
WITH CHONDROCYTES
Biotinylated Fn-fs were added to a final concentration of
1 M to cultured cartilage. After 2 days, the cartilage was
cryosectioned and the sections were treated with avidin-
HRP and diaminobenzidine substrate as described13. The
control tissue was not cultured with Fn-fs; sections were
treated with avidin-HRP and substrate to control for non-
specific binding of conjugate.
To visualize interaction of rhodamine labeled 29-kDa
Fn-f with chondrocytes, the Fn-f was labeled with NHS-
rhodamine by reacting 0.5 mg/ml Fn-f in 50 mM phosphate
buffer, pH 7.4, containing 150 mM NaCl, with 0.1 mg/ml
NHS-rhodamine for 2 h on ice as recommended by the
supplier, Pierce Chemical Co. The Fn-f solution was then
dialyzed exhaustively against the phosphate buffer and
added to low density chondrocyte monolayer cultures
(5×105 cells/cm2) in DMEM for a final concentration of
1 M Fn-f. After 48 h, the excess Fn-fs were washed
away with the phosphate buffer and the remaining label
visualized by fluorescence and phase microscopy.DTSSP CROSS-LINKING OF CHONDROCYTES
Chondrocytes were plated in 10% serum/DMEM into
6 cm dishes and after 3–4 days, medium switched to
DMEM. Biotinylated BSA, Fn-fs or Fn were then added for
a final concentration of 1 M. After 48 h at 37°C, the
medium was removed, the cells washed three times and
2 ml fresh 50 mM phosphate buffer, pH 7.4, containing
150 mM NaCl, added to each 6 cm dish. A 10% volume ofreagents, if the Fn-fs bound at or near the alpha5 subunit of
this receptor within the chondrocyte cell membrane.
940 G. A. Homandberg et al: Fibronectin fragments bind alpha5 integrin25 mM DTSSP, freshly prepared in water, was then added.
After 2 h at room temperature, the reaction was stopped
with 1 M Tris, pH 7.4. The dish was then washed three
times with the phosphate buffer and the cells lysed by
addition of 1.0 ml of 50 mM octylglucoside in 50 mM Tris,
pH 7.4, containing 150 mM NaCl, 0.05% azide, 10 mM m-
gCl2 and 0.1 mM phenylmethylsulfonyl fluoride. A solution
of 0.1% SDS, 0.1% deoxycholate, 1% NP-40, 150 mM
NaCl, 50 mM Tris, pH 7.4, as described19 was also tested
but was found not to be as optimal in solubilizing the alpha5
subunit. After 15 min, the suspension was clarified by
centrifugation. The pellet, representing about 5% of the
supernatant volume, was resuspended in 0.2 ml of
Laemmli denaturation buffer for subsequent analysis by
Western blotting. The final lysate supernatant from each
6 cm dish represented about nine million cells in 1.0 ml. In
order to apply the equivalent of about 0.2–1 million cells per
electrophoresis lane, the lysate was dialysed against a
20-fold dilution of the lysis buffer for 12 h and then concen-
trated 10–20-fold by lyophilization prior to electrophoresis
and Western blotting. The samples were denatured
for electrophoresis using Laemmli denaturation buffer.
Reducing agent was not added since the cross-linking
reagent contains a disulfide. The lysate supernatant was
tested for extent of reaction, prior to complete analysis, by
reacting a Western blot of the samples with avidin-HRP to
detect an increase in mass of biotinylated Fn-fs or reacting
with antialpha5 antibodies to detect changes in mass of the
Fn receptor subunit.
Other aliquots of the lysate were applied to antialpha5-
agarose in order to trap receptor and detect the presence of
cross-linked biotinylated Fn-f. Antialpha5-agarose was
made by reacting 25 g of rabbit antialpha5 in 1 ml sodium
bicarbonate buffer, pH 8.2, with 1 ml of activated agarose
for 24 h at 9°C. For affinity chromatography, 100 l aliquots
of unconcentrated lysate from 0.3 million cells were added
to 60 l aliquots of antialpha5-agarose. Other aliquots were
applied to 60 l aliquots of strepavidin-agarose to trap
biotinylated Fn-f and test for the presence of receptor. The
mixtures were allowed to shake for 12 h at 9°C. The resins
were then washed four times with 50 mM phosphate buffer,
pH 7.4, containing 150 mM NaCl and the mixture pelleted.
A 50 l of Laemmli denaturation buffer, without disulfide
reducing agent, was added to each pelleted substituted
agarose slurry and a 10–20 l aliquot of denatured sample
was applied to each electrophoresis lane. After electro-
phoresis and Western blotting, the blot was reacted with
avidin-HRP or antialpha5 antibody as described above.PHOTOAFFINITY LABELING AND ANALYSIS OF RESULTANT LYSATES
To determine whether the alpha5 subunit was cross-
linked under conditions in which only proteins physically
close to the biotinylated Fn or Fn-fs could be cross-linked,
the following method was used: aliquots of freshly prepared
photoaffinity labeled biotinylated Fn-fs or Fn were added to
chondrocyte cultures in 4.5 ml of DMEM in 6 cm dishes in a
dark room with only red light illumination, for a final con-
centration of 1 M. In some experiments, the specificity of
the SAED-protein was tested by co-addition to the chondro-
cyte cultures of a five-fold excess of non-labeled Fn-fs or
Fn. The cultures were continued for 48 h in a CO2 incubator
and then exposed to a germicidal UV light in a cell culture
hood for 1 h. The media were then removed and to each
culture dish was added 1 ml of octylglucoside solution as
described above. The lysate was then dialysed against a10-fold dilution of the octylglucoside solution and finally
concentrated 10–20× by lyophilization. A 10–20 l aliquot
was applied to each lane of an SDS gel and the gel
subjected to Western blotting and the blot reacted with
antialpha5 antibody.
In order to substantiate further that the alpha5 protein
had biotinylated Fn or Fn-f attached, the lysate was purified
over antialpha5-agarose prior to Western blotting. Culturing
and the final lysis of the cultures were performed as
described above. The specificity was also tested by
co-addition of a five-fold excess of non-biotinylated
Fn-fs or Fn with the addition of the photoafffinity-labeled
biotinylated-Fn-fs and Fn. Aliquots of about 100 l of
unconcentrated lysate equivalent to 0.3–0.7 million cells
from each incubation were added to 60 l aliquots of
antialpha5-agarose and adherent material recovered as
described above. The bound and eluted material was
subjected to electrophoresis and the resultant blot reacted
with avidin-HRP.WESTERN BLOTTING AND CHEMILUMINESCENT DETECTION FOR
BIOTINYLATED PROTEIN AND FOR ALPHA5 PROTEIN
A 10 l aliquot of a 10-fold concentrated cell lysate was
applied to 7% acrylamide SDS gels and blotted onto
nitrocellulose for 18 h at 30 V, followed by 1 h at 90 V. The
blot was then treated for 1 h with 50 mM phosphate buffer,
pH 7.4, containing 150 mM NaCl as well as 3% BSA, in
order to block non-specific absorption sites. For detection
of biotinylated protein, an ECL kit from Pierce Chemical Co.
was used according to the manufacturer’s protocol. The
blot was then reacted for 1 h with avidin-HRP in a 20 000
fold dilution of 1 mg/ml conjugate in phosphate buffer, also
containing 1% BSA and 0.05% Tween-20. After washing six
times with phosphate buffer-Tween 20 for 15 min each, the
blot was then reacted with ECL pre-mixed substrate solu-
tion for 1 min and the blot then placed in a clear membrane
protector and the assembly placed on a Kodak X-Omat
sheet for less than 2 min.
For detection of alpha5 protein, after blocking the blot
with BSA, the blot was reacted with 7 g/ml rabbit anti-
alpha5 antibody for 1 h, followed by six washes with the
phosphate buffer for 15 min per wash. The blot was then
reacted with HRP conjugated goat antirabbit IgG (Sigma
# A-0545; 1:40 000 titer by direct ELISA) for 1 h (1:20 000
fold dilution of 1 mg/ml with phosphate buffer also contain-
ing 0.05% Tween 20 and 1% BSA). The blot was then
developed with ECL substrate.CAPTURE OF ALPHA5BETA1 FN RECEPTOR FROM CHONDROCYTE
LYSATES
Chondrocyte lysate from 22 million cells in 0.5 ml was
added to 400 l of antialpha5-agarose overnight at 9°C with
gentle stirring. The antialpha5-agarose was then washed
three times with 50 mM phosphate buffer, pH 7.4, also
containing 150 mM NaCl and 10 mM mgCl2. An aliquot of
about 60 l of antialpha5-resin in 0.5 ml in 50 mM Tris
buffer, pH 7.4, also containing 50 mM NaCl and 10 mM
mgCl2, was then reacted with 2 g/ml of biotinylated BSA,
29-kDa, 50-kDa, 140-kDa Fn-f or with biotinylated Fn. Each
reaction contained the equivalent of about three million
cells. The reaction was allowed to continue for 24 h at 9°C,
the antialpha5-agarose then washed three times with
50 mM phosphate buffer, pH 7.4, containing 150 mM NaCl,
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SDS denaturation buffer. The samples were subjected to
electrophoresis on 7% acrylamide gels, the gels blotted
and the blots reacted with avidin-HRP to detect the pres-
ence of biotinylated Fn-fs. The equivalent of about one
million cells per lane was used for detection. To control for
non-specific absorption to antibody, lysate and biotinylated
Fn-fs and Fn, were also added to goat antirabbit IgG-
Sepharose. To control for non-specific binding of bio-
tinylated protein to antialpha5-agarose, biotinylated Fn-fs
and Fn were added to aliquots of antialpha5-agarose
not treated with lysate. To investigate specificity, a 10-
fold excess of non-biotinylated protein was added with
the biotinylated protein to the lysate/antialpha5 agarose
mixtures.TESTS OF INTERACTION BETWEEN ALPHA5BETA1-AGAROSE AND
BIOTINYLATED FN-FS
Purified alpha5beta1 receptor (Chemicon International
Corp.), 10 g in 500 l of 0.1 M sodium carbonate buffer,
pH 8.3, containing 1 mM mgCl2 and 0.1% Triton X-100,
were reacted 18 h at 9°C with 3 ml of Reacti-gel (Pierce
Chemical Co., Rockford, IL) in a total volume of 5 ml of the
same buffer. After washing the alpha5beta1-agarose with
50 mM Tris buffer, pH 7.4, also containing 150 mM NaCl,
1 mM mgCl2, 1 mg/ml BSA and 0.1% Triton X-100, an
aliquot containing 1 g of each biotinylated Fn-f or bio-
tinylated Fn in the same buffer was added to 50 l of
packed alpha5beta1-agarose After agitation for 24 h at 9°C,
the resins were washed three times with 50 mM phosphate
buffer, pH 7.4, containing 150 mM NaCl, and 50 l of
Laemmli denaturation buffer were added. The samples
were heat denatured, the supernatants recovered and
subjected to electrophoresis on 7% acrylamide gels, the
gels blotted and the blots reacted with avidin-HRP.QUANTITATIVE ASSAY OF BINDING OF FN-FS TO
ALPHA5BETA1-AGAROSE
To quantify interaction of Fn or Fn-fs with alpha5beta1-
agarose, 500 l aliquots of proteins (0.5 mg/ml) in 50 mM
phosphate buffer, pH 7.4, containing 150 mM NaCl, were
reacted with 20 l of 5 mCi/ml 125I-Bolton Hunter reagent
(in benzene/DMF mixture from manufacturer) overnight at
9°C. The solutions were dialysed against five changes of
200 ml of 50 mM Tris buffer, pH 7.4, containing 150 mM
NaCl, 1 mM mgCl2, 1 mg/ml BSA and 0.1% Triton X-100.
The final specific activities were 2372, 779, 750, 2100 and
5850 dpm/pmole, respectively, for BSA, 29-kDa, 50-kDa,
140-kDa Fn-f and native Fn. This represented a range of 13
to 35 dpm/pg. Next, an aliquot equivalent to 75 l packed
resin of alpha5beta1-agarose was placed into Eppendorf
tubes and equilibrated with the same Tris buffer for 24 h.
The supernatants were then discarded and the volumes
adjusted to 1 ml with the Tris buffer. Increasing volumes of
125I-labeled BSA, Fn or Fn-fs were then added and the
contents agitated for 2 h at room temperature. The con-
tents were then centrifuged, washed with 1 ml of equilibra-
tion buffer, re-centrifuged and the bound label to the
alpha5beta1-agarose and the label in the supernatant
separately counted. Duplicate samples were analysed and
the averages used for graphical analysis.RESULTS
THE 29-KDA FN-FS BOUND TO CHONDROCYTES EITHER IN
CARTILAGE TISSUE OR IN MONOLAYER CULTURE
To confirm that a major target of the Fn-fs was the cell
surface, chondrocytes in low density monolayer culture in
DMEM 3 days after plating were reacted with rhodamine
labeled 29-kDa Fn-f for 48 h. Figure 1(A) shows a phase
contrast micrograph of cells treated with fluorescent rhod-
amine labeled BSA and B shows the fluorescent profile of
the same field. Note the absence of fluorescence. Figure
1(C) shows a phase micrograph of cells treated with
fluorescent 29-kDa Fn-f, while (D) shows the same field
visualized by fluorescence microscopy. The labeled Fn-f
surrounded the cells. Not all the cells were labeled, per-
haps due to chondrocyte heterogeneity. The binding of
Fn-fs to chondrocytes within cartilage tissue was examined
next, using biotinylated Fn-f and avidin-HRP as a second-
ary probe. This type of labeling was used rather than
fluorescence in order to reduce background. Figure 1(E)
shows the lack of background stain in cartilage incubated
only with avidin-HRP as a control, while panel (F) is of
cartilage treated with biotinylated-BSA, followed by reac-
tion with avidin-HRP and substrate. Panel (G) is of cartilage
treated with biotinylated 29-kDa Fn-f, followed by avidin-
HRP and substrate. Note the localization of label around
the cells as well on the superficial surface. The labeling on
the superficial surface suggests that the Fn-f may have
some matrix interaction, yet label is not evident in the
deeper matrix. Thus, a major target of the 29-kDa Fn-f
appears to be on the cell surface whether the cells are in
monolayer culture or cartilage tissue and binding does not
require the extensive matrix of cartilage explants. Thus,
monolayer cultures were used to identify the targets of
the Fn-fs. In other experiments, we found that the 50-kDa
and 140-kDa Fn-fs, as well as Fn, bound to chondrocyte
monolayers as well as surrounded cells in explant cultures
(data not shown).THE FN-F WERE CROSS-LINKED TO THE ALPHA5 SUBUNIT AS
SHOWN BY CROSS-LINKING WITH DTSSP
Since a major target of the Fn-fs could be on the
chondrocyte cell membrane or in the pericellular space, we
attempted next to determine if one of the targets included
the alpha5 integrin subunit. Since affinity isolation of the
reactive partners could have been complicated by weak
interactions or interference by other matrix components, we
used a chemical cross-linking approach to investigate prox-
imity of the partners. To increase selectivity and sensitivity
in the analysis, biotinylated Fn-fs were prepared for probing
the interaction. The three Fn-fs described in Methods were
biotinylated and found to be fully active in enhancing PG
degradation in cultured cartilage (Methods).
The biotinylated Fn-fs were then added to high density
chondrocytes monolayer cultures and after 24 h, the cross-
linker added. The cells were then lysed and the lysate and
pellets examined for any changes in the mass of alpha5
subunit material. Figure 2(A) shows that the addition of
biotinylated protein by itself, without DTSSP, did not
change the position of the alpha5 subunit.
However, panel (B) shows that with DTSSP, conversion
of the subunit into higher molecular weight complexes
occurred. Note that since the samples were not reduced,
the reactive material smeared and did not form discrete
942 G. A. Homandberg et al: Fibronectin fragments bind alpha5 integrinFig. 1. Interaction of rhodamine-labeled 29-kDa Fn-f with chondrocytes in monolayer culture and of biotinylated Fn-f with cartilage tissue. For
microscopy of chondrocyte monolayers, panels (A)–(D), chondrocytes in DMEM were incubated with 1 M rhodamine-labeled BSA or
29-kDa Fn-f for 48 h, followed by washing and fluorescence microscopy. Panel (A) shows phase microscopy (100×) after treatment with
rhodamine labeled BSA and B shows fluorescence (100×) of same field. Panel (C) shows phase microscopy of rhodamine-labeled 29-kDa
Fn-f (100×) and panel (D) shows fluorescence (100×). For microscopy of cartilage tissue, explants in DMEM were incubated with 1 M
biotinylated BSA or 29-kDa Fn-f for 48 h, followed by cryosectioning and reaction of sections with avidin-HRP and substrate. Panel (E) shows
control tissue, not treated with BSA or Fn-f. The sections were treated with avidin-HRP and substrate only. Panels (F) and (G) shows
cartilage cultured, respectively, with biotinylated BSA or 29-kDa Fn-f and after culture, the resultant sections treated with avidin-HRP and
substrate. Cartilage tissue was visualized at 60×.bands. Thus, throughout our studies, receptor or Fn-f
complexes were smeared on SDS gels when samples were
not reduced. As shown by the C(−) and C(+) lanes in panel
(B), which correspond, respectively, to deletion and
addition of DTSSP but no biotinylated-Fn-f or Fn in either
case, conversion into high molecular weight complexes
required DTSSP but still occurred in the absence of added
BSA, Fn-f or Fn. Thus, conversion into higher molecular
weight mass could not be used as a single criterion to
confirm reaction with Fn-fs.
For the samples in panel (C), the lysate was probed with
avidin-HRP to detect the presence of biotinylated protein.
The control lanes show that bands were only detected
when biotinylated Fn-f or Fn was added. The BSA lane
shows that biotinylated BSA did not remain bound when the
cells were washed prior to lysis. In contrast, the Fn-f and Fnlanes show that these ligands remained bound prior to
cross-linking and after cross-linking became incorporated
into higher molecular weight complexes, above the mass of
the individual alpha5 subunit.
Figure 3 shows an analysis of the cross-linking by
visualization of the distribution of biotinylated Fn-f, Fn and
BSA after adsorption on to antialpha5-agarose of the lysate
from cross-linked chondrocytes. This purification step was
included since, as shown above, changes in mobility of
either the biotinylated Fn-f or alpha5 protein could not be
used to infer cross-linking between the two. After affinity
adsorption and elution, the material was then blotted
against avidin-HRP to determine if the alpha5 protein
containing material also contained biotinylated Fn-f or Fn.
Figure 3(a) shows that complexes containing both the
alpha subunit and biotinylated Fn-f or native Fn, were5
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the presence of biotinylated Fn-fs and Fn. Chondrocytes were
adjusted to biotinylated BSA, Fn-f or Fn for a final concentration of
1 M. After 48 h, the cells were lysed and the supernatants of the
lysates subjected to Western blotting on a 7% acrylamide gel and
reaction with antialpha5 antibody. Panel (A) shows a Western blot
of lysate from an experiment in which DTSSP was deleted. Shown
are control, C(−), not reacted with Fn-f or cross-linker), BSA (B)
and Fn-f and Fn treated samples. Panel (B) shows similar samples
from an experiment in which DTSSP was included. Three times as
much material was applied to gels, as compared with panel A, to
allow for visualization in the presence of smearing. C(+) and C(−)
correspond, respectively, to addition or deletion of DTSSP but no
included biotinylated Fn-f or Fn. Panel (C) shows the results of
probing the lysate of cross-linked material with avidin-HRP.Fig. 3. Detection of DTSSP cross-linked biotinylated Fn-f/alpha5
complexes after affinity adsorption of lysates onto antialpha5-
agarose. Panel (A): samples generated as in Fig. 2 from DTSSP
treated chondrocytes were reacted with antialpha5-agarose, the
agarose subjected to denaturation buffer, the eluted material
subjected to electrophoresis on a 7% acrylamide SDS gel and the
gel blotted. The Western blot was probed with avidin-HRP to detect
biotinylated Fn-fs. C(+) and C(−) correspond, respectively, to
addition or deletion of DTSSP but no included biotinylated Fn-f or
Fn. B corresponds to BSA. Panel (B): similar samples as in panel
(A) were subjected to reduction after affinity chromatography and
the samples run on a 10% acrylamide gel, followed by blotting and
probing with avidin-HRP.recovered as shown in the 29, 50, 140 and Fn lanes. The
complexes smeared from the position of the individual
subunit to masses greater than 300-kDa, probably because
the lack of disulfide reduction may not have allowed gen-
eration of homogeneous SDS micelles. The samples in the
140-kDa and Fn lanes appeared to have the greatest
amount of attached biotin label. In all lanes there was some
material close to an apparent mass of 120-kDa, the
approximate size of the subunit. Since the minimal mass of
Fn-f/alpha5 complexes should have been 150-kDa for the
29-kDa complex and 620-kDa for the Fn/alpha5 complex,
label at the 120-kDa position is likely to be due to smearingof the non-reduced, incompletely denatured less soluble
SDS micelles. The C(−) and C(+) lanes that corresponded,
respectively, to deletion and inclusion of cross-linker, had
no detectable biotinylated protein. The BSA lane shows
that biotinylated BSA was not recovered after the isolation.
When the purified material was subjected to disulfide
reduction and the samples probed with avidin-HRP, the
biotinylated Fn-f and Fn were recovered at their expected
masses [Fig. 3(B)]. As above, the control and BSA lanes
showed the expected result, absence of biotinylated pro-
tein. When the cross-linking experiments did not contain
DTSSP but did contain biotinylated BSA, Fn-f or Fn, the
resultant blots did not show a reaction with avidin-HRP
(data not shown).
Attempts were made to trap all biotinylated-Fn-f contain-
ing material and test for the presence of the alpha5 protein,
as well as other potential receptor subunits. However, when
the lysate was applied to strepavidin-agarose resin, the
resin eluted and the samples reacted with antibodies to
alpha5, prominent bands were not detected, suggest-
ing that the Fn-f/alpha complex may have been diluted5
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components.USING MORE SPECIFIC CHEMISTRY, PHOTOAFFINITY LABELED
BIOTINYLATED FN-F AND FN CROSS-LINKED TO THE ALPHA5
SUBUNIT
A photoaffinity label approach was used next in order to
direct cross-linking only to those proteins proximal to the
biotinylated Fn-fs or Fn. A photoaffinity label, SAED, was
attached to the biotinylated Fn-fs in the dark, this derivative
added to cells and after activating the cross-linker with UV
light, the cell lysate analysed. This derivative was found to
be fully active in enhancing rates of PG degradation in
cultured cartilage (Methods). Since the only way the alpha5
mobility would be altered is if the Fn-fs were proximal to the
alpha5 subunit and cross-linking occurred, purification of
the complex should have not been necessary. Specificity
was tested by co-addition of an excess of unlabeled Fn or
Fn-fs.
Upon analysis of the lysates by Western blotting and
reaction of the blots with antialpha5, proximity of the Fn-fs
and the subunit was confirmed in this second approach.
Panels (A) and (B) in Fig. 4 show that BSA (PB) did not
alter the alpha5 mobility while each photoaffinity labeled (P)
Fn-f and Fn did. Also, in this case, smearing of the resultant
complexes occurred. Addition of an excess of unlabeled Fn
or Fn-f in each case (+N) decreased the extent of conver-
sion to higher molecular weight forms. In the case of the
three Fn-fs, the excess has allowed visualization of a
prominent 120-kDa band, the alpha subunit.5Panel (C) shows a blot of lysate not reacted with anti-
alpha5 but instead with avidin-HRP in order to confirm that
the biotinylated Fn-fs were incorporated into higher mass
complexes. The panel shows that the range of masses of
the biotinylated Fn/Fn-f complexes was similar to those
found for the alpha5 protein complexes. For panel (D), the
lysates were reduced in an attempt to recover the cross-
linked subunit. The blot shows that this treatment has
liberated the alpha5 protein from the complex.
Although the alpha5 containing complexes did not have
to be purified for the analysis since a shift in their mass
should have provided sufficient evidence of proximity to
biotinylated Fn-fs, for additional confirmation we applied
the lysates to an antialpha5-agarose column and then
analysed the bound material for the presence of bio-
tinylated Fn or Fn-fs. The purified alpha5 material distrib-
uted in a range of masses of less than 140-kDa as well as
above an apparent mass of 250-kDa for Fn and all three
Fn-fs (data not shown). Analysis on a larger pore 5%
acrylamide gel showed smearing to a mass greater than
500-kDa.Fig. 4. Detection of photoaffinity cross-linked biotinylated Fn-f/alpha5 complexes. Chondrocyte cultures were incubated with photoaffinity
labeled biotinylated proteins. Some cultures were exposed to photoaffinity labeled proteins in the presence of a 10-fold excess of the
respective unlabeled protein, as indicated by (+N). The lysates were subjected to electrophoresis and the gels blotted. Panels (A) and (B)
show control cultures (not exposed to protein) (C), photolabeled BSA treated cultures (PB) and photoaffinity labeled Fn-f and Fn treated
cultures (designated by P) that were probed with antialpha5. Panel (C) is a blot derived from lysates that were probed with avidin-HRP to
detect biotinylated protein. Panel (D) is a blot corresponding to lysate that was reduced, blotted and then reacted with antialpha5. Arrow on
right in all panels is the expected position of the alpha5 subunit.ALPHA5 SUBUNIT CAPTURED FROM LYSATES ALSO BOUND FN AND
FN-FS
The cross-linking studies had demonstrated that the Fn
or Fn-fs bound close enough to be cross-linked, but these
studies could not be used to demonstrate direct interaction.
Consequently, an attempt was made to capture the alpha5
protein on antialpha5-agarose and test interaction with
biotinylated Fn-fs or Fn as described in Methods. This
Osteoarthritis and Cartilage Vol. 10, No. 12 945experiment required several controls. Binding of bio-
tinylated Fn-fs to antialpha5-agarose that was not exposed
to lysate, binding of biotinylated Fn-fs to immobilized irrel-
evant antibody that had been first exposed to lysate and
binding to alpha5-agarose that was first exposed to lysate
but in the presence of an excess of nonbiotinylated protein,
were tested.
Panels (A) and (B) in Fig. 5 show that application of
lysate to the antialpha5 agarose captured both alpha5 and
beta1 subunits, respectively. Panels (C) through (F) show
that without lysate (-lys) applied to the agarose resins there
was no detectable binding of biotinylated Fn-fs or Fn.
Substitution of a non-specific antibody-agarose (+nsAb)
did not lead to non-specific binding of biotinylated Fn-fs
although biotinylated Fn did show some interaction.
However, specific interaction did occur with addition of
lysate antialpha5 agarose (exp) and this interaction was
decreased or blocked by co-addition of a 10-fold excess of
cold Fn-fs or Fn (+comp).Fig. 5. Interaction of biotinylated Fn-fs with antialpha5-agarose saturated with lysate containing alpha5 protein. Lysate from 22 million cells
was added to antialpha5-agarose overnight with stirring. The resin was then washed and incubated with biotinylated proteins. The resin was
then washed and finally treated with SDS denaturation buffer. The samples were subjected to electrophoresis on 7% acrylamide gels for
biotinylated Fn but 10% gels for the other Fn-fs, the gels blotted and the blots reacted with avidin-HRP to detect the presence of biotinylated
Fn-fs. Panels (A) and (B) are blots of resin saturated with lysate and probed with antialpha5 antibody or with antibeta1, respectively. Panels(C), (D), (E) and (F) are resin samples that have been probed with the respective biotinylated proteins indicated on the bottom. The first lane
(-lys) in each case is a control in which biotinylated protein, but not lysate, was added to the alpha5 resin. The second lane (+NSAb)
corresponds to substitution of alpha5 resin with goat antirabbit IgG agarose but with added lysate and biotinylated protein. The third lane(+comp) corresponds to co-addition of a 10-fold excess of unlabeled Fn-f or Fn to test for specificity. The fourth lane (exp) corresponds to
the complete experiment of addition of lysate and biotinylated protein to antialpha5-agarose.PURIFIED ALPHA5BETA1 ALSO BOUND FN-FS AND FN
Since the outcome of the above experiment might have
been influenced by other proteins that bound to the alpha5
during the isolation, whether or not the Fn-fs would bind to
purified alpha5beta1 receptor protein that was coupled to
agarose was also tested. This purified receptor became
commercially available after we performed the above
studies. The biotinylated Fn-fs or Fn were added at the
same molar quantities, which were all equivalent to 1 gnative Fn, in 1 ml volumes to 1 ml of receptor-agarose. For
a control, biotinylated proteins were also passed over
BSA-agarose. The substituted agarose resins were then
washed and 50 l aliquots subjected to Laemmli denatura-
tion buffer. The desorbed material was blotted and probed
with avidin-HRP.
The Western blot in Fig. 6(A) shows that there was no
significant binding of Fn-fs or Fn to the BSA-agaroses.
However, as shown in Fig. 6(B), all three Fn-fs and Fn
bound to the alpha5beta1-agarose. In other experiments,
reversibility of binding was tested. Resin saturated with
125I-labeled Fn-fs or with Fn were allowed to equilibrate in
buffer with addition of Fn-f or Fn. In each case, 50%
dissociation occurred within 24 h, suggesting reversibility.
After an additional 48 h, 75–90% of the original ligand had
dissociated.
In order to quantify the binding, increasing amounts
of 125I-labeled proteins were added in the presence or
absence of 10-fold molar excesses of the respective
unlabeled protein, in order to correct for non-specific bind-
ing. The amount of non-specific binding of all of the Fn-fs
varied from typically 21–30%. As shown in Fig. 7(A), after
correction for non-specific binding, each Fn-f bound in a
concentration dependent manner and bound to a greater
extent than did native Fn. Binding of biotinylated BSA was
not concentration dependent and, thus, probably not
specific.
The data were also plotted in a Scatchard plot as shown
in Fig. 7(B) and linear regression analysis performed of the
slopes resulting in r2 values of 0.87, 0.85, 0.99 and 0.95,
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Fn. The plot shows that the affinities of the three Fn-fs were
much weaker than that of native Fn, with approximate Kd
values for the 29-kDa, 50-kDa, 140-kDa Fn-fs and Fn, of
3.9 (±) 0.43 M, 2.5 (±) 0.29 M, 0.5 (±) 0.12 M and 0.13
(±) 0.09 M, respectively. The X intercepts suggest that
18.5, 16.1, 5.3 and 1.8 pmol of 29-kDa, 50-kDa, 140-kDa
Fn-fs and Fn, respectively, bound to about 1 pmol of
receptor (based on protein assays) coupled to the agarose.
Since native Fn is dimeric, 0.9 pmol of Fn subunit bound
1 pmol of receptor. We conclude that the binding of Fn-fs to
the receptor was not only weaker than native Fn but also
multimeric.Fig. 6. Interaction of biotinylated Fn-fs with purified alpha5beta1
receptor-agarose. Purified receptor coupled to Reacti-gel was
reacted with biotinylated proteins and after 24 h, the washed
alpha5beta1 receptor-agarose subjected to denaturation buffer and
the recovered supernatant subjected to Western blotting from 7%
acrylamide gels and detection with avidin-HRP. Biotinylated
proteins were also added simultaneously to BSA coupled to
Reacti-gel. Panels (A) and (B) show the results of adsorption on to
and elution from BSA-agarose and alpha5 agarose, respectively.5Fig. 7. Interaction of radiolabeled Fn-fs with purified alpha5beta1
receptor-agarose. Panel A, increasing quantities of 125I-labeled
Fn-fs, Fn and BSA were added to alpha5beta1 protein bound to
Reacti-gel. After 2 h, the amount bound to alpha5beta1 receptor-
agarose was determined by subjecting the resin to gamma count-
ing. In a parallel series, a 10-fold excess of unlabeled protein was
added to correct for non-specific binding. The non-specifically
bound was subtracted from the total and plotted as shown in panel
(A). Panel (B), data corrected for non-specific binding, were
converted into a Scatchard plot.Discussion
Our preliminary data suggested that the alpha5beta1
RGDS dependent Fn receptor integrin, the major Fn recep-
tor in chondrocytes19 was at least partly responsible for
Fn-f activities. Other data from this laboratory also con-
firm the role of the alpha5 in Fn-f activities in that anti-
sense oligonucleotides to the alpha subunit significantlydecrease the activity of the Fn-fs18. Our objective here was
to determine whether the Fn-fs bound at or near the alpha5
subunit of this receptor in chondrocytes. This objective was
particularly important since not all of the Fn-fs that are
active in causing cartilage damage are known to bind
directly to Fn receptors. Of the three Fn-fs, an amino-
terminal 29-kDa Fn-f, a 50-kDa gelatin binding Fn-f
(C-terminal to the 29-kDa in the chain) and a 140-kDa
cell-binding Fn-f, only the 140-kDa Fn-f has been clearly
established to bind to Fn receptors. In fact, the alpha5beta1
receptor was isolated by affinity chromatography to cell-
binding Fn-f-resin25. None the less, we showed that the
29-kDa Fn-fs bound around chondrocytes in monolayer
cultures. The binding pattern was similar to that shown for
binding of Fn-fs to chondrocytes in cartilage explants6,8
and did include some binding on the superficial surface,
although interaction with the matrix in the middle zone
was not evident6,8. Preliminary observations by con-
focal microscopy do confirm that the Fn-f bind the
plasma membrane (R. Joseph and G.A. Homandberg,
unpublished).
Chondrocytes express several different types of
integrins, including the alpha1beta1, alpha5beta1 and
alphaVbeta5 as well as lesser quantitities of the alpha3beta1
and alphaVbeta3 heterodimers26. The alpha5beta1 as well
as the alpha3beta1 integrins bind Fn, while the latter
receptor can also bind laminin and collagens27,28. The
alpha1beta1, alpha2beta1 and alpha10beta1 receptors bind
types II and VI collagen, the alpha6,beta1 integrin binds
laminin and the alpha beta integrins binds vitronectin andV 3
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beta1 subunits, the levels of which are altered by cartilage
degeneration in human OA30 and in a non-human primate
model of OA31.
The alpha5 subunit was the focus of our studies and not
the beta1 subunit because the alpha5 subunit has been
shown to be involved in specificity determination and the
beta1 can complex with other alpha subunits 1–6 and
alphaV (reviewed32), which do not all bind Fn. Our experi-
mental approach focused on use of cross-linking reagents
to determine if the Fn-fs bound near the alpha5 subunit
because of concern that affinity chromatography might fail
for weaker interactions and consideration that the Fn-fs
might bind near the receptor but not directly to it. Two
different chemical cross-linking approaches were used. In
the first, biotinylated Fn-fs were cross-linked to all potential
binding sites. This was a more convenient approach but
because of the extensive cross-linking of all available
proteins, the material had to be purified for definitive
analysis. In the second approach, the Fn-fs were first
photoaffinity labeled so only the Fn-f targets would be
chemically modified and purification would not be
necessary.
In the first approach, visualization of the DTSSP cross-
linked complexes showed that the biotinylated Fn-fs and Fn
had increased their apparent masses upon cross-linking.
Subsequent disulfide reduction of the lysates liberated the
biotinylated Fn-fs as well as Fn, all of which migrated with
the correct mobilities for their masses. The lysates were
then purified on antialpha5 resin and found to contain
biotinylated Fn-fs. Biotinylated BSA was not found in
lysates from BSA treated and purified material. The masses
of the Fn-f cross-linked alpha5 protein appeared to be
250-kDa and greater, however, an accurate mass could
not be obtained without reduction and this would have
abolished the cross-linking.
The alpha5 subunit was confirmed as a target of the
Fn-fs by use of the second method where a highly specific
photoaffinity approach was used. SAED, a heterobifunc-
tional, primary amine-reactive, water soluble, thiol cleav-
able photoactivatable cross-linker was coupled to bio-
tinylated Fn-fs. It was assumed that upon activation of this
derivative, a shift in mass of the alpha5 subunit would
confirm the proximity of the subunit to the Fn-fs or Fn. All
three Fn-fs and Fn, but not BSA, altered the alpha5 mobility
and addition of an excess of unlabeled Fn-f or Fn
decreased the effect. The cross-linked material was puri-
fied further by affinity to alpha5-resin and was confirmed to
contain alpha5 protein in complex with Fn and Fn-fs.
We were unable to isolate the complexes by affinity to
strepavidin-agarose and this limited a search for other
binding partners. This difficulty could have arisen because
the cross-linked Fn-fs or Fn became less accessible to the
strepavidin arm on the agarose or because the Fn-fs
reacted with so many targets that the Fn-f-alpha5 protein
complex became too dilute to detect in the presence of all
of the other potential complexes.
Since the cross-linking data only suggested close prox-
imity, but not necessarily direct interaction, the ability of
biotinylated Fn-fs to bind to antialpha5-agarose saturated
with lysate was tested. Both the alpha5 and beta1 subunits
were found in adherent material. Fn and all three Fn-fs, but
not BSA, bound to the saturated antialpha5-agarose. In
other experiments, we also tested binding to agarose
substituted with purified alpha5beta1 receptor. Again Fn and
all three Fn-f, but not BSA, bound. With the latter study we
attempted to quantify the interaction and found thatalthough the Fn-fs bound to the purified alpha5beta1 sub-
stituted agarose, the interactions were much weaker and
the stoichiometry greater than interaction of receptor with
Fn. These data suggest a weak multisite interaction of
Fn-fs or interaction of self-associated or aggregated Fn-fs
with the purified receptor. We propose that the weaker
affinities and higher stoichiometries of the Fn-fs as com-
pared with native Fn may be because the smaller Fn-f can
either self-associate as we have reported24 and these
complexes may bind the subunit or instead the Fn-fs may
bind as monomers but bind very weakly to unique sites of
the subunit that would not be possible with the same
domains in native Fn. Either mode may account for the
stoichiometry, e.g., for the 29-kDa Fn-f, in which up to 20
molecules apparently bound one molecule of receptor. The
estimated affinity of the 29-kDa Fn-f for the alpha5 subunit
was very weak and made it more difficult to dissect out
complicated profiles from Scatchard plots. Thus, we cannot
deduce whether our data indicate similar sites or multiple
modes of interaction. None the less, it should be noted that
others have recently also shown that amino-terminal Fn-fs
can bind to isolated alpha5beta1, although no quantitative
analysis was provided33.
The demonstration that the amino-terminal 29-kDa and
50-kDa Fn-fs are active in causing cartilage damage and
bind to the alpha5 subunit may seem at odds with the
earlier dogma in which only the 140-kDa cell binding Fn-f
was thought to bind directly to the receptor. However, there
are many observations supporting the direct interaction of
the amino-terminal domains with cell surfaces or pericellu-
lar matrix. For example, amino-terminal Fn-fs inhibit peri-
cellular matrix assembly34 and block interaction of receptor
with receptor antibodies35. The interaction of cell surfaces
with the amino-terminal 29-kDa segment has been shown
to be required for formation of a Fn matrix and the matrix in
turn has been shown to increase binding of this segment36.
It has also been reported that the presence of the
alph5beta1 integrin is necessary for binding of the amino-
terminal segment36 although it has been shown that stable
overexpression of the alpha3 integrin in integrin deficient
CHO B2 cells allows binding of this Fn-f37. It has also been
shown that this amino-terminal segment binds Fn fibrils,
since both Fn and the receptor are required for binding of
the amino-terminal segment of Fn to cells38–41.
Since the amino-terminal Fn-f bind matrix, it is plausible
that their mechanism of action could involve their ability to
interfere with binding of native Fn to either the receptor or
to fibrils or competitively displace Fn and thus alter the
composition and signaling character of the pericellular
matrix. This detachment of Fn from receptor may have
drastic consequences. For example, in the absence of
attachment to Fn, integrin alpha5beta1 expression activates
a pathway leading to decreased cellular proliferation of
HT29 colon carcinoma cells while ligation of receptor with
Fn reverses this signal42. Further, disruption of binding of
Fn to the alpha5beta1 integrin stimulates cyclin dependent
kinases and DNA synthesis and activation of MAP
kinases43.
The implication of the alpha5beta1 integrin in this Fn-f
model also suggests that this biochemical pathway inter-
sects at the level of this integrin with biomechanical
pathways of cartilage degeneration. For example, it has
been shown that normal and osteoarthritic human articular
chondrocytes also use the alpha5beta1 receptor as a mech-
anoreceptor since after mechanical stimulation of this
integrin a signal cascade is initiated, that involves stretch-
activated ion channels, the actin cytoskeleton and tyrosine
948 G. A. Homandberg et al: Fibronectin fragments bind alpha5 integrinphosphorylation of the focal adhesion complex molecules
pp125 focal adhesion kinase and paxillin and beta-
catenin44. The importance of this receptor in OA is
further suggested by the observation from the same
laboratory that there are differences in downstream
alpha5beta1 mediated signaling between normal and OA
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